Top Clinical Trials companies in Spain by Price to Earnings Ratio (P/E)
This ranking features the top 1 Clinical Trials companies in Spain ranked by Price to Earnings Ratio (P/E), averaging a Price to Earnings Ratio (P/E) of -26.45, for January 15, 2025.
Spain
Clinical Trials
Price to Earnings Ratio (P/E)
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
-26.45 |
Jan. 14, 2025 | USD 1.51 | -0.07% |
|
Spain |
Frequently Asked Questions
-
Which Clinical Trials company in Spain has the highest Price to Earnings Ratio (P/E) ?
The Clinical Trials company in Spain with the highest Price to Earnings Ratio (P/E) is Oryzon Genomics S.A. (MCE: ORY.MC) at -26.45.
-
Which Clinical Trials company in Spain has the lowest Price to Earnings Ratio (P/E) ?
The Clinical Trials company in Spain with the lowest Price to Earnings Ratio (P/E) is Oryzon Genomics S.A. (MCE: ORY.MC) at -26.45.
-
What are the top 10 Clinical Trials companies in Spain by Price to Earnings Ratio (P/E) ?
The top 10 Clinical Trials companies in Spain by Price to Earnings Ratio (P/E) are and Oryzon Genomics S.A..
-
What are the bottom 10 Clinical Trials companies in Spain by Price to Earnings Ratio (P/E) ?
The bottom 10 Clinical Trials companies in Spain by Price to Earnings Ratio (P/E) are and Oryzon Genomics S.A..